Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells.

J Neuroimmunol 2003 Dec;145(1-2):55-67

Department of Pathology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

Development of tumors is regulated by tumor-derived neuroendocrine factors, including bombesin-like peptides (BLP). We have evaluated neuroendocrine regulation of dendritic cell (DC) maturation and function by both tumor-derived and purified bombesin (BOM), neuromedin B (NMB), gastrin-releasing peptide (GRP), and a BOM antagonist D-Phe-bombesin (DPB). BOM, NMB and GRP dose-dependently inhibited maturation of DC assessed as down-regulation of CD40, CD80 and CD86 expression on DC. BOM and GRP also inhibited interleukin-12 (IL-12) production by DC and their ability to activate T cells. DPB partly abrogated immunosuppressive effect of tumor cells on DC. These data are a first evidence for the role of BLP in the regulation of DC maturation and function, demonstrating that BLP inhibit DC maturation and longevity in the lung cancer microenvironment. This suggests a new mechanism of tumor escape and provides new targets for the immunopharmacological correction of immune effectors in cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2003.09.009DOI Listing
December 2003
22 Reads

Publication Analysis

Top Keywords

bombesin-like peptides
8
maturation function
8
bom grp
4
grp inhibited
4
expression bom
4
cd86 expression
4
cd80 cd86
4
inhibited interleukin-12
4
interleukin-12 il-12
4
activate cells
4
cells dpb
4
ability activate
4
production ability
4
il-12 production
4
cd40 cd80
4
down-regulation cd40
4
d-phe-bombesin dpb
4
dpb bom
4
peptide grp
4
antagonist d-phe-bombesin
4

Similar Publications